CMG Pharmaceutical Co., Ltd. (KOSDAQ:058820)

South Korea flag South Korea · Delayed Price · Currency is KRW
1,791.00
+1.00 (0.06%)
Apr 29, 2026, 10:10 AM KST
-30.85%
Market Cap 268.19B
Revenue (ttm) 105.23B
Net Income (ttm) -10.08B
Shares Out 147.84M
EPS (ttm) -70.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 164,750
Average Volume 488,645
Open 1,789.00
Previous Close 1,790.00
Day's Range 1,786.00 - 1,806.00
52-Week Range 1,670.00 - 2,620.00
Beta 0.64
RSI 48.09
Earnings Date Apr 3, 2026

About CMG Pharmaceutical

CMG Pharmaceutical Co., Ltd., a pharmaceutical company, develops and sells oral thin film (OTF) pharmaceuticals in South Korea. It offers Tadalafil OTF products for erectile dysfunction; Entecavir OTF products to treat hepatitis type B; Aripiprazole OTF products for schizophrenia; and Montelukast OTF products to treat asthma and allergic rhinitis. CMG Pharmaceutical Co. Ltd. has a strategic collaboration agreement with Handok Inc. for cancer treatment. The company was formerly known as Skynewpharm Co Ltd and changed its name to CMG Pharmaceutic... [Read more]

Sector Healthcare
Founded 2001
Employees 223
Stock Exchange KOSDAQ
Ticker Symbol 058820
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.